HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Li Selected Research

SM905

3/2008The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Li Research Topics

Disease

389Neoplasms (Cancer)
02/2024 - 01/2000
106Infections
02/2024 - 01/2000
87Neoplasm Metastasis (Metastasis)
05/2023 - 01/2000
83Inflammation (Inflammations)
04/2024 - 03/2000
61Breast Neoplasms (Breast Cancer)
12/2023 - 01/2000
51Carcinogenesis
11/2022 - 02/2000
49Stomach Neoplasms (Stomach Cancer)
03/2024 - 04/2002
42Hemorrhage
03/2024 - 02/2000
42Stroke (Strokes)
01/2024 - 01/2000
39Body Weight (Weight, Body)
04/2024 - 03/2000
39Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 07/2001
37Carcinoma (Carcinomatosis)
04/2023 - 08/2000
36Hepatocellular Carcinoma (Hepatoma)
06/2023 - 01/2000
35Prostatic Neoplasms (Prostate Cancer)
01/2022 - 09/2000
34Insulin Resistance
01/2023 - 03/2000
32Fibrosis (Cirrhosis)
05/2023 - 03/2000
31Type 2 Diabetes Mellitus (MODY)
05/2023 - 10/2001
28Hypoxia (Hypoxemia)
09/2022 - 08/2000
27Hypertension (High Blood Pressure)
01/2024 - 01/2000
27Pain (Aches)
05/2023 - 06/2000
27Necrosis
04/2022 - 03/2000
27Lymphatic Metastasis
02/2022 - 02/2000
26Obesity
12/2022 - 06/2000
25Wounds and Injuries (Trauma)
07/2023 - 06/2000
25Thrombosis (Thrombus)
02/2023 - 08/2000
24Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 02/2001
24Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 11/2000
24Asthma (Bronchial Asthma)
09/2023 - 03/2001
23Lung Neoplasms (Lung Cancer)
04/2022 - 02/2000
23Adenocarcinoma
03/2022 - 02/2000
23Ischemia
11/2017 - 04/2000
21Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 06/2007
21Leukemia
10/2021 - 01/2000
20Aplastic Anemia (Anemia, Hypoplastic)
10/2023 - 04/2014
20Squamous Cell Carcinoma of Head and Neck
07/2023 - 03/2000
20Melanoma (Melanoma, Malignant)
05/2023 - 04/2000
20Reperfusion Injury
01/2022 - 02/2000
20Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2000
20Ovarian Neoplasms (Ovarian Cancer)
11/2020 - 07/2000
19Myocardial Infarction
04/2024 - 03/2001
19Osteoarthritis
09/2022 - 08/2001
17Colonic Neoplasms (Colon Cancer)
10/2023 - 02/2000
17Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2022 - 06/2001
16Rheumatoid Arthritis
04/2024 - 04/2000
16Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 01/2001
15Hyperplasia
04/2024 - 09/2001
15Infarction (Infarctions)
01/2024 - 07/2000
15Human Influenza (Influenza)
07/2022 - 11/2000
15Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021 - 02/2000
15Aneurysm (Aneurysms)
09/2021 - 10/2000
14Acquired Immunodeficiency Syndrome (AIDS)
11/2023 - 01/2000

Drug/Important Bio-Agent (IBA)

218Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2000
75Messenger RNA (mRNA)IBA
01/2024 - 01/2000
71Biomarkers (Surrogate Marker)IBA
01/2024 - 06/2000
53CytokinesIBA
01/2024 - 02/2000
52DNA (Deoxyribonucleic Acid)IBA
04/2022 - 01/2000
50Glucose (Dextrose)FDA LinkGeneric
05/2024 - 03/2000
49AntigensIBA
12/2021 - 01/2000
45MicroRNAs (MicroRNA)IBA
11/2020 - 07/2008
32EnzymesIBA
06/2021 - 05/2000
31RNA (Ribonucleic Acid)IBA
01/2022 - 01/2000
30AntibodiesIBA
06/2023 - 02/2000
30VaccinesIBA
01/2023 - 03/2000
29Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2022 - 01/2001
29Long Noncoding RNAIBA
09/2021 - 03/2014
28Small Interfering RNA (siRNA)IBA
10/2022 - 08/2007
27Insulin (Novolin)FDA Link
01/2023 - 03/2000
26LipidsIBA
08/2023 - 03/2001
25Interleukin-6 (Interleukin 6)IBA
03/2024 - 01/2000
23LigandsIBA
01/2024 - 01/2000
22Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 02/2000
20CollagenIBA
04/2024 - 01/2000
20Transcription Factors (Transcription Factor)IBA
01/2024 - 07/2000
20InterleukinsIBA
10/2023 - 04/2001
19AntioxidantsIBA
01/2022 - 02/2000
18Oxygen (Dioxygen)IBA
02/2024 - 03/2000
18Blood Glucose (Blood Sugar)IBA
01/2024 - 01/2000
18Indicators and Reagents (Reagents)IBA
10/2023 - 10/2000
18Monoclonal AntibodiesIBA
09/2023 - 10/2000
18Therapeutic UsesIBA
09/2023 - 02/2000
18Peptides (Polypeptides)IBA
11/2021 - 04/2000
17Cisplatin (Platino)FDA LinkGeneric
10/2022 - 07/2001
16Hormones (Hormone)IBA
06/2023 - 05/2001
16Interleukin-10 (Interleukin 10)IBA
01/2022 - 02/2001
16salicylhydroxamic acid (SHAM)IBA
01/2021 - 03/2000
15Matrix Metalloproteinases (MMPs)IBA
04/2024 - 01/2000
15CholesterolIBA
10/2023 - 06/2000
15AutoantibodiesIBA
10/2023 - 12/2001
14Interleukin-17 (Interleukin 17)IBA
01/2024 - 03/2008
14Hemoglobins (Hemoglobin)IBA
10/2023 - 03/2000

Therapy/Procedure

213Therapeutics
10/2023 - 01/2000
74Drug Therapy (Chemotherapy)
06/2023 - 01/2000
42Transplantation
04/2022 - 03/2000
28Radiotherapy
10/2023 - 09/2000
26Stents
01/2024 - 06/2007
24Aftercare (After-Treatment)
05/2023 - 03/2000
23Immunotherapy
02/2024 - 11/2002
18Lasers (Laser)
03/2024 - 01/2000
17Length of Stay
11/2023 - 01/2013
15Lymph Node Excision (Lymph Node Dissection)
04/2023 - 07/2006